Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Kriegeskorte

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Medicine|May 8, 2012
Horizontal gene transfer boosts MRSA spreadingAndré Kriegeskorte, Georg Peters
International Journal of Medical Microbiology : IJMM|July 19, 2014
Methicillin resistance in Staphylococcus isolates: the "mec alphabet" with specific consideration of mecC, a mec homolog associated with zoonotic S. aureus lineagesKarsten Becker, Britta Ballhausen, Robin Köck, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
The mecA homolog mecC confers resistance against β-lactams in Staphylococcus aureus irrespective of the genetic strain backgroundBritta Ballhausen, André Kriegeskorte, Nina Schleimer, et al.
Plos One|May 16, 2012
Catheter colonization and abscess formation due to Staphylococcus epidermidis with normal and small-colony-variant phenotype is mouse strain dependentGunnar Sander, Tina Börner, André Kriegeskorte, et al.
Frontiers in Cellular and Infection Microbiology|August 15, 2014
Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infectionsRichard A Proctor, André Kriegeskorte, Barbara C Kahl, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
<i>In Vitro</i> Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam AntibioticsEvgeny A Idelevich, André Kriegeskorte, Nina Schleimer, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2011
Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypesEvgeny A Idelevich, André Kriegeskorte, William Stubbings, et al.
Diagnostic Microbiology and Infectious Disease|December 18, 2018
Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysisDennis Knaack, Evgeny A Idelevich, Nina Schleimer, et al.
Veterinary Microbiology|May 30, 2016
The pathogenicity and host adaptation of livestock-associated MRSA CC398Britta Ballhausen, André Kriegeskorte, Sarah van Alen, et al.
Environmental Microbiology|April 30, 2015
The culturome of the human nose habitats reveals individual bacterial fingerprint patternsUrsula Kaspar, André Kriegeskorte, Tanja Schubert, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Medicine|May 8, 2012
Horizontal gene transfer boosts MRSA spreadingAndré Kriegeskorte, Georg Peters
International Journal of Medical Microbiology : IJMM|July 19, 2014
Methicillin resistance in Staphylococcus isolates: the "mec alphabet" with specific consideration of mecC, a mec homolog associated with zoonotic S. aureus lineagesKarsten Becker, Britta Ballhausen, Robin Köck, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
The mecA homolog mecC confers resistance against β-lactams in Staphylococcus aureus irrespective of the genetic strain backgroundBritta Ballhausen, André Kriegeskorte, Nina Schleimer, et al.
Plos One|May 16, 2012
Catheter colonization and abscess formation due to Staphylococcus epidermidis with normal and small-colony-variant phenotype is mouse strain dependentGunnar Sander, Tina Börner, André Kriegeskorte, et al.
Frontiers in Cellular and Infection Microbiology|August 15, 2014
Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infectionsRichard A Proctor, André Kriegeskorte, Barbara C Kahl, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
<i>In Vitro</i> Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam AntibioticsEvgeny A Idelevich, André Kriegeskorte, Nina Schleimer, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2011
Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypesEvgeny A Idelevich, André Kriegeskorte, William Stubbings, et al.
Diagnostic Microbiology and Infectious Disease|December 18, 2018
Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysisDennis Knaack, Evgeny A Idelevich, Nina Schleimer, et al.
Veterinary Microbiology|May 30, 2016
The pathogenicity and host adaptation of livestock-associated MRSA CC398Britta Ballhausen, André Kriegeskorte, Sarah van Alen, et al.
Environmental Microbiology|April 30, 2015
The culturome of the human nose habitats reveals individual bacterial fingerprint patternsUrsula Kaspar, André Kriegeskorte, Tanja Schubert, et al.
Pageof 2